Neuromuscular Blockade Monitoring

Clinical Studies

Click on each title for the links

Operating Room

2023

2021

2020

2020

2020

2016

2016

An algorithm to estimate the speed of recovery from rocuronium induced neuromuscular blockade, a prospective observational study. Acta Anaesthesiol. 

Brunetti A, Fuchs-Buder T, Bidgoli SJ, Schmartz D.

Comparison of the TOFscan and the TOF-Watch SX during Recovery of Neuromuscular Function

Nora Colegrave , Valérie Billard, Cyrus Motamed, Jean-Louis Bourgain 

A modified TOF-ratio to assess rocuronium-induced neuromuscular block: a comparison with the usual TOF-ratio 2016

Denis Schmartz, Paul Bernard, Raouf Sghaier , Jean-Francois Fils, Thomas Fuchs-Buder

Intensive Care

2011

2021

2020

2017

2021

2002

2019

2017

2019

2. Neuromuscular monitoring and neuromuscular blocking agent shortages when treating critically ill COVID-19 patients: a multicentre retrospective analysis

Julia Ziatkowski-Michaud, Tessa Mazard, Marie-Charlotte Delignette, Florent Wallet, Frederic Aubrun, Mikhail Dziadzko

3. Technologies to Optimize the Care of Severe COVID-19 Patients for Health Care Providers Challenged by Limited Resources

Rubulotta, Francesca MD, PhD, MBA, FRCA, FICM; Soliman-Aboumarie, Hatem MD, FEACVI, FASE, FHEA; Filbey, Kevin MD; Geldner, Goetz MD, PhD; Kuck, Kai PhD; Ganau, Mario MD, PhD, FEBNS, FACS‖; Hemmerling, Thomas M. MSc, MD, DEAA

4. How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study

Sami Hraiech, Jean-Marie Forel, Christophe Guervilly, Romain Rambaud, Samuel Lehingue, Mélanie Adda, Pierre Sylla, Sabine Valera, Julien Carvelli, Marc Gainnier, Laurent Papazian, Jérémy Bourenne

5. Neuromuscular blockade management in patients with COVID-19

Harold Chaves-Cardona, Vivian Hernandez-Torres, Sean Kiley, Johnathan Renew

6. A comparison of two depths of prolonged neuromuscular blockade induced by cisatracurium in mechanically ventilated critically ill patients

Franck Lagneau, Gilles D’honneur, Benoît Plaud, Jean Mantz, Thierry Gillart, Philippe Duvaldestin, Jean Marty, Nathalie Clyti, Jean-Louis Pourriat

7. Current Use of Neuromuscular Blocking Agents in Intensive Care Units

Büşra Tezcan, Sema Turan, Ayşegül Özgök

1. https://sfar.org/utilisation-des-curares-en-reanimation/

2. Neuromuscular monitoring and neuromuscular blocking agent shortages when treating critically ill COVID-19 patients: a multicentre retrospective analysis

Julia Ziatkowski-Michaud, Tessa Mazard, Marie-Charlotte Delignette, Florent Wallet, Frederic Aubrun, Mikhail Dziadzko

3. Technologies to Optimize the Care of Severe COVID-19 Patients for Health Care Providers Challenged by Limited Resources

Rubulotta, Francesca MD, PhD, MBA, FRCA, FICM; Soliman-Aboumarie, Hatem MD, FEACVI, FASE, FHEA; Filbey, Kevin MD; Geldner, Goetz MD, PhD; Kuck, Kai PhD; Ganau, Mario MD, PhD, FEBNS, FACS‖; Hemmerling, Thomas M. MSc, MD, DEAA

4. How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study

Sami Hraiech, Jean-Marie Forel, Christophe Guervilly, Romain Rambaud, Samuel Lehingue, Mélanie Adda, Pierre Sylla, Sabine Valera, Julien Carvelli, Marc Gainnier, Laurent Papazian, Jérémy Bourenne

5. Neuromuscular blockade management in patients with COVID-19

Harold Chaves-Cardona, Vivian Hernandez-Torres, Sean Kiley, Johnathan Renew

6. A comparison of two depths of prolonged neuromuscular blockade induced by cisatracurium in mechanically ventilated critically ill patients

Franck Lagneau, Gilles D’honneur, Benoît Plaud, Jean Mantz, Thierry Gillart, Philippe Duvaldestin, Jean Marty, Nathalie Clyti, Jean-Louis Pourriat

7. Current Use of Neuromuscular Blocking Agents in Intensive Care Units

Büşra Tezcan, Sema Turan, Ayşegül Özgök